A combination of chemotherapy and immunotherapy for the first time shows superiority over chemotherapy alone in metastatic bladder cancer Published on 08/10/2019 Dr. Enrique Grande, head of the Medical Oncology Service at MD Anderson Madrid – Hospiten, is co-chair of the IMvigor130 clinical trial, which has evaluated the efficacy of this combination in front line treatment